Evidence map›Paper›PMID 34420024›Full record

ArticleOtology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology2021

Primary Vestibular Schwannoma Cells Activate p21 and RAD51-Associated DNA Repair Following Radiation-Induced DNA Damage.

Torin P Thielhelm, Stefania Goncalves, Scott Welford, Eric A Mellon, Olena Bracho, Michael Estivill, Clifford Brown, Jacques Morcos, Michael E Ivan, Fred Telischi and 2 more

Open access · greenAbstract read
In one paragraph

Article in Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. RAD51 Inhibitor and Radiation Toxicity in Vestibular Schwannoma.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2022
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Torin P ThielhelmDepartment of Otolaryngology, University of Miami Miller School of Medicine.
Stefania GoncalvesDepartment of Otolaryngology, University of Miami Miller School of Medicine.
Scott WelfordDepartment of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine.
Eric A MellonDepartment of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine.
Olena BrachoDepartment of Otolaryngology, University of Miami Miller School of Medicine.
Michael EstivillDepartment of Otolaryngology, University of Miami Miller School of Medicine.
Clifford BrownDepartment of Otolaryngology, University of Miami Miller School of Medicine.
Jacques MorcosDepartment of Neurological Surgery, University of Miami Miller School of Medicine.
Michael E IvanDepartment of Neurological Surgery, University of Miami Miller School of Medicine.
Fred TelischiDepartment of Otolaryngology, University of Miami Miller School of Medicine.
Cristina Fernandez-ValleBurnett School of Biomedical Sciences, University of Central Florida, College of Medicine, Orlando, Florida.
Christine T DinhDepartment of Otolaryngology, University of Miami Miller School of Medicine.
University of Miami · USFlorida College · USNeurological Surgery · USSylvester Comprehensive Cancer Center · US

Funding

Polyamine Catabolism and Therapeutic Resistance in Glioblastoma MultiformeR01CA187053 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WELFORD, SCOTT MICHAEL · 2015 to 2025
$3.5M
Preclinical Testing of PI3K Inhibitors for Vestibular SchwannomasR01DC017264 · NIDCD · UNIVERSITY OF CENTRAL FLORIDA · PI FERNANDEZ-VALLE, CRISTINA MARIA, LIU, XUE Z · 2018 to 2022
$3.1M
Tumor-Mediated Hearing Loss in Neurofibromatosis Type IIK08DC017508 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DINH, CHRISTINE THUYVAN · 2019 to 2023
$840k
Co-targeting FAK and PI3K for NF2 SchwannomasR56NS102254 · NINDS · UNIVERSITY OF CENTRAL FLORIDA · PI FERNANDEZ-VALLE, CRISTINA MARIA · 2018 to 2018
$462k
NCI NIH HHS R01 CA187053NIDCD NIH HHS K08 DC017508NIDCD NIH HHS L30 DC018981NIDCD NIH HHS R01 DC017264NINDS NIH HHS R56 NS102254
6 · The paper itself

Abstract

hypothesisVestibular Schwannoma (VS) can avoid cell death following radiation injury by entering cell cycle arrest and activating RAD51-related DNA repair.

backgroundAlthough the radiobiology of various cancers is well-studied, the radiobiological effects in VS are poorly understood. In this study, we describe how VS cells enter cell cycle arrest (through p21 expression), activate DNA repair (through RAD51 upregulation), and avoid cell death after radiation-induced double-stranded breaks (DSB) in DNA (as measured by γ-H2AX).

methodsPrimary human VS cells were cultured on 96-well plates and 16-well culture slides at 10,000 cells/well and exposed to either 0 or 18 Gray of radiation. Viability assays were performed at 96 h in vitro. Immunofluorescence for γ-H2AX, RAD51, and p21 was performed at 6 h.

resultsRadiation (18 Gy) induced the expression of γ-H2AX, p21, and RAD51 in six cultured VS, suggesting that irradiated VS acquire DSBs, enter cell cycle arrest, and initiate RAD51 DNA repair to evade cell death. However, viability studies demonstrate variable responses in individual VS cells with 3 of 6 VS showing radiation resistance to 18 Gy. On further analyses, radiation-resistant VS cells expressed significantly more p21 than radiation-responsive tumors.

conclusionsIn response to radiation-induced DNA damage, primary VS cells can enter cell cycle arrest and express RAD51 DNA repair mechanisms to avoid cell death. Radioresistant VS cells may mount a more robust p21 response to ensure sufficient time for DNA repair. Further investigation into DNA repair proteins and cell cycle checkpoints may provide important insight on the radiobiology of VS and mechanisms for resistance.

Indexed as

Neuroma, AcousticRadiation InjuriesCell LineDNA Breaks, Double-StrandedDNA RepairHumansRad51 RecombinaseRAD51 protein, humanRad51 Recombinase

Identifiers

PMID34420024
PMCPMC8595670
OpenAlexW3196005740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.